# No-biopsy Approach in Celiac Disease: Cut-off Points for IgA Anti-tissue Transglutaminase Assays

> **NCT05983978** · — · RECRUITING · sponsor: **Instituto de Investigación Hospital Universitario La Paz** · enrollment: 150 (estimated)

## Conditions studied

- Celiac Disease

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05983978
- **Lead sponsor:** Instituto de Investigación Hospital Universitario La Paz
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2023-01-02
- **Primary completion:** 2026-03-31
- **Final completion:** 2026-03-31
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2025-08-06

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05983978

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05983978, "No-biopsy Approach in Celiac Disease: Cut-off Points for IgA Anti-tissue Transglutaminase Assays". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05983978. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*